You just read:

One-Year Results from Positive Phase 3 EYLEA Trial in Diabetic Retinopathy Presented at Angiogenesis Symposium

News provided by

Regeneron Pharmaceuticals, Inc.

Feb 09, 2019, 16:30 ET